Dry eye workshops assist ODs with protocol

Article

Scott Schachter, OD, discusses how the Dry Eye WorkShop (DEWS I) and upcoming DEWS II announcement at ARVO in May can help ODs form an effective dry eye protocol at their practices.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Scott Schachter, OD, discusses how the Dry Eye WorkShop (DEWS I) and upcoming DEWS II announcement at ARVO in May can help ODs form an effective dry eye protocol at their practices.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Related Content
Image of PROSE lenses Image credit: BostonSight

Study investigates PROSE lenses as drug delivery device for patients with dry eye disease

Jordana Joy, Associate Editor
December 6th 2024
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
Woman sitting at OCT machine Image credit: AdobeStock/Parilov

The vitreous—remember me?

Jim Williamson, OD, FAAO, FORS
December 4th 2024
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
Man holding cigarette and whiskey glass at table Image credit: AdobeStock/Parkin

BMI, tobacco, and alcohol: Roles in glaucoma progression examined in study

Lynda Charters
December 3rd 2024
Article
Tibetan flags on mountainside Image credit: AdobeStock/mrallen

Factors influencing ocular pain in patients with dry eye in Tibet

Lynda Charters
December 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.